Cefepime Shortage in 2026: What's Going On?

If you've recently been told that Cefepime is unavailable, backordered, or in limited supply at your hospital or pharmacy, you're dealing with a problem that has affected thousands of patients across the United States. Cefepime — a critical IV antibiotic used to treat life-threatening infections — has been on and off the drug shortage list for years.

In this update, we'll give you the latest on where things stand in 2026, explain why the shortage keeps happening, cover the current cost picture, and share practical steps you can take to get the treatment you need.

Is Cefepime Still in Shortage?

Cefepime injection has experienced intermittent shortages since the early 2010s. The drug has been listed on both the FDA Drug Shortage Database and the ASHP (American Society of Health-System Pharmacists) shortage tracking list multiple times. While supply improves during some periods, disruptions continue to recur.

The situation in 2026 remains challenging. Several factors continue to strain supply:

• Manufacturing quality issues at sterile injectable facilities
• A limited number of producers — Sandoz exited the market in 2016, and the Maxipime brand was discontinued
• Ongoing demand from hospitals, especially during respiratory illness seasons
• Global supply chain disruptions affecting raw materials and shipping

For a deeper explanation of why this keeps happening, read Why Is Cefepime So Hard to Find?

Why Is Cefepime Hard to Find?

Cefepime is a sterile injectable medication, which means it must be manufactured under extremely controlled conditions. This class of drugs — sterile injectables — accounts for the majority of all drug shortages in the U.S.

Here's why Cefepime specifically keeps running into problems:

Fewer Manufacturers Than You'd Think

Generic sterile injectables operate on thin profit margins. This has pushed some manufacturers out of the market. When Sandoz discontinued its Cefepime line in 2016, the remaining producers — including Hospira/Pfizer, Baxter, B. Braun, Hikma, and Sagent — have had to carry the full market demand. When any one of them has a production issue, it creates a ripple effect across the entire supply.

Quality and Manufacturing Delays

Producing sterile injectable antibiotics requires specialized equipment, cleanroom environments, and rigorous quality control. Contamination events, equipment failures, or FDA inspection findings can shut down production lines for weeks or months.

Unpredictable Demand Spikes

When infection rates surge — whether from seasonal respiratory illness, new resistance patterns, or other factors — hospitals need more Cefepime than forecasted. The supply chain for sterile injectables has very little slack to absorb sudden demand increases.

What Does Cefepime Cost in 2026?

The cost of Cefepime varies depending on the formulation, quantity, and where you receive it:

• Cash price (without insurance): Approximately $90 to $365 for a typical treatment course (e.g., 9 vials of 2 g), depending on the pharmacy
• With discount cards: Prices as low as $50 to $93 through programs like SingleCare or GoodRx
• Individual vials: Generic Cefepime vials typically range from $5 to $45 each depending on the dose and supplier
• Hospital pricing: If you receive Cefepime during an inpatient hospital stay, the cost is usually included in your facility charges and billed through your insurance

For more ways to reduce your costs, check out How to Save Money on Cefepime in 2026.

Are There New Options for Patients?

While no new brand-name versions of Cefepime have launched recently, a few developments are worth noting:

• Cefepime-Enmetazobactam (Exblifep): A newer combination product that pairs Cefepime with a beta-lactamase inhibitor. It was approved for complicated UTIs and may offer an option when standard Cefepime isn't available, depending on your infection type.
• Alternative antibiotics: Your doctor may consider Piperacillin-Tazobactam (Zosyn), Meropenem, or Ceftazidime as substitutes depending on your culture and sensitivity results.
• Extended infusion protocols: Some hospitals have adopted extended infusion dosing (infusing Cefepime over 3–4 hours instead of 30 minutes) to optimize drug levels and potentially reduce the total amount of drug needed.

How to Find Cefepime in Stock

If you need Cefepime and are having trouble finding it, here's what to do:

1. Use Medfinder: Go to medfinder.com and search for Cefepime to see which pharmacies and infusion centers near you have it in stock.
2. Ask about specialty pharmacies: Home infusion pharmacies and specialty compounding pharmacies sometimes have access to different supply channels.
3. Contact your hospital pharmacy: Hospital pharmacists manage shortage protocols and may be able to source Cefepime through emergency supply channels or partner institutions.
4. Talk to your doctor: If Cefepime cannot be found, your doctor can review your options and switch to an effective alternative quickly.

For a complete guide, read How to Find Cefepime in Stock Near You.

Final Thoughts

The Cefepime shortage is frustrating, but understanding the situation gives you power to act. The shortage is driven by manufacturing challenges, a shrinking number of producers, and demand spikes that the supply chain can't easily absorb.

Stay proactive by using tools like Medfinder, communicating early with your healthcare team, and being open to alternative treatments when needed. Your health doesn't have to wait — the right support and information can help you navigate this shortage safely.